On September 29,2022, appointed by Comrade Zeng bin, secretary-general of the Chengdu high-tech Medical Association and Director of the Center for Medical Integration and collaborative innovation, deputy Director of the Center for Medical Integration and innovation of the Chengdu high-tech Medical Association, Bu Wei, and business development director of the Chengdu high-tech bio-pharmaceutical Park Management Co. , Ltd. , Xiao Haibo and his team, we have visited Chengdu Weijin Boao Biomedicine Technology Co. , Ltd. , Chengdu Huitai Biomedicine Co. , Ltd. and Nuofeng Pharmaceutical (Chengdu) Co. , Ltd. , the three companies had exchanges and discussions on the landing of science and Technology Innovation Projects and enterprise financial services.

During the period, the three companies introduced in detail their project product pipeline and Enterprise Development Planning, and combined with their existing project defined the needs of the enterprise.

The director of the Business Development Department of Chengdu Gaotou Biomedicine Park Management Co. , Ltd. said that the park's current positioning goal is“BT + IT”, the participants were briefed on the node paths and operation strategies of the park to focus on the four major directions of Internet + medical health services, artificial intelligence (bio-information) + precision medicine, artificial intelligence + medical devices, and medical device sales and circulation. He also fully affirmed the role of the Chengdu high-tech Medical Association, stressing that the medical staff integration and innovation center of the Chengdu high-tech Medical Association, while assisting in attracting the Phoenix and building the nest in the park, focus more on solving the“Growth problem” in the development process of enterprises, especially in strategic investment, technology integration, capital guidance, consulting services and other key obstacles to the development of enterprises generally appear on the upgrade of the key difficulties for enterprises to solve problems and escort, is to help park high-quality development, help enterprises in-depth contact with the upstream and downstream partners of the industry, group development of the“Accelerator” nature of the organization, is an important advisory body in urgent need of the industry.

After the meeting, the parties agreed to take this visit as an opportunity to further accelerate the integration of industry resources, to help enterprises transform innovation, technology transformation. The society will continue to build and integrate the innovation and development of the biomedical industry, link the industry, build platforms, expand channels, promote inclusive development, and accelerate the transformation process of scientific and technological achievements in the biomedical industry, for the development of the industry to play their due ability and role.